142 related articles for article (PubMed ID: 37160765)
1. Enhancement of Valsartan Oral Bioavailability by Preparing a Microwave-Irradiated Inclusion Complex with Sulfobutyl Ether β-Cyclodextrin Using a Central Composite Face Design for Optimising Process Parameters.
Maddula VR; Dachuru RSR
AAPS PharmSciTech; 2023 May; 24(5):115. PubMed ID: 37160765
[TBL] [Abstract][Full Text] [Related]
2. Polymer-free electrospun nanofibers from sulfobutyl ether
Yildiz ZI; Celebioglu A; Uyar T
Int J Pharm; 2017 Oct; 531(2):550-558. PubMed ID: 28445768
[TBL] [Abstract][Full Text] [Related]
3. Inclusion complex of erlotinib with sulfobutyl ether-β-cyclodextrin: Preparation, characterization, in silico, in vitro and in vivo evaluation.
Devasari N; Dora CP; Singh C; Paidi SR; Kumar V; Sobhia ME; Suresh S
Carbohydr Polym; 2015 Dec; 134():547-56. PubMed ID: 26428157
[TBL] [Abstract][Full Text] [Related]
4. The interaction of charged and uncharged drugs with neutral (HP-beta-CD) and anionically charged (SBE7-beta-CD) beta-cyclodextrins.
Okimoto K; Rajewski RA; Uekama K; Jona JA; Stella VJ
Pharm Res; 1996 Feb; 13(2):256-64. PubMed ID: 8932446
[TBL] [Abstract][Full Text] [Related]
5. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
Badr-Eldin SM; Elkheshen SA; Ghorab MM
Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of oral bioavailability of cilostazol by forming its inclusion complexes.
Patel SG; Rajput SJ
AAPS PharmSciTech; 2009; 10(2):660-9. PubMed ID: 19459053
[TBL] [Abstract][Full Text] [Related]
7. Water-soluble beta-cyclodextrins in paediatric oral solutions of spironolactone: preclinical evaluation of spironolactone bioavailability from solutions of beta-cyclodextrin derivatives in rats.
Kaukonen AM; Lennernäs H; Mannermaa JP
J Pharm Pharmacol; 1998 Jun; 50(6):611-9. PubMed ID: 9680070
[TBL] [Abstract][Full Text] [Related]
8. Formulation and characterization of eprosartan mesylate and β-cyclodextrin inclusion complex prepared by microwave technology.
Ahad A; Bin Jardan YA; Hassan MZ; Raish M; Ahmad A; Al-Mohizea AM; Al-Jenoobi FI
Drug Deliv; 2022 Dec; 29(1):1512-1522. PubMed ID: 35549506
[TBL] [Abstract][Full Text] [Related]
9. Enhanced Oral Bioavailability of Epalrestat SBE
Alvi Z; Akhtar M; Mahmood A; Ur-Rahman N; Nazir I; Sadaquat H; Ijaz M; Syed SK; Waqas MK; Wang Y
Int J Nanomedicine; 2021; 16():8353-8373. PubMed ID: 35002232
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of a sulfobutyl ether beta-cyclodextrin as a solubilizing/stabilizing agent for several drugs.
Ueda H; Ou D; Endo T; Nagase H; Tomono K; Nagai T
Drug Dev Ind Pharm; 1998 Sep; 24(9):863-7. PubMed ID: 9876538
[TBL] [Abstract][Full Text] [Related]
11. Pharmaceutical composition of valsartan: beta-cyclodextrin: physico-chemical characterization and anti-hypertensive evaluation.
Jensen CE; dos Santos RA; Denadai AM; Santos CF; Braga AN; Sinisterra RD
Molecules; 2010 Jun; 15(6):4067-84. PubMed ID: 20657427
[TBL] [Abstract][Full Text] [Related]
12. Febuxostat ternary inclusion complex using SBE7-βCD in presence of a water-soluble polymer: physicochemical characterization, in vitro dissolution, and in vivo evaluation.
Sakran W; Abdel-Hakim M; Teiama MS; Abdel-Rashid RS
Drug Deliv Transl Res; 2024 Jul; 14(7):1909-1922. PubMed ID: 38185775
[TBL] [Abstract][Full Text] [Related]
13. Optimization of sulfobutyl-ether-β-cyclodextrin levels in oral formulations to enhance progesterone bioavailability.
Shankar VK; Police A; Pandey P; Cuny ZG; Repka MA; Doerksen RJ; Murthy SN
Int J Pharm; 2021 Mar; 596():120212. PubMed ID: 33493605
[TBL] [Abstract][Full Text] [Related]
14. Development of morin/hydroxypropyl-β-cyclodextrin inclusion complex: Enhancement of bioavailability, antihyperalgesic and anti-inflammatory effects.
Lima BDS; Campos CA; da Silva Santos ACR; Santos VCN; Trindade GDGG; Shanmugam S; Pereira EWM; Marreto RN; Duarte MC; Almeida JRGDS; Quintans JSS; Quintans LJ; Araújo AAS
Food Chem Toxicol; 2019 Apr; 126():15-24. PubMed ID: 30738132
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of oral bioavailability of anti-HIV drug rilpivirine HCl through nanosponge formulation
Zainuddin R; Zaheer Z; Sangshetti JN; Momin M
Drug Dev Ind Pharm; 2017 Dec; 43(12):2076-2084. PubMed ID: 28845699
[TBL] [Abstract][Full Text] [Related]
16. Sulfobutyl ether(7) β-cyclodextrin (SBE(7) β-CD) carbamazepine complex: preparation, characterization, molecular modeling, and evaluation of in vivo anti-epileptic activity.
Jain AS; Date AA; Pissurlenkar RR; Coutinho EC; Nagarsenker MS
AAPS PharmSciTech; 2011 Dec; 12(4):1163-75. PubMed ID: 21918921
[TBL] [Abstract][Full Text] [Related]
17. Preparation and
Al-Heibshy FNS; Başaran E; Öztürk N; Demirel M
Drug Dev Ind Pharm; 2020 Sep; 46(9):1495-1506. PubMed ID: 32804005
[TBL] [Abstract][Full Text] [Related]
18. Stimulatory Effects of Soluplus® on Flufenamic Acid β-Cyclodextrin Supramolecular Complex: Physicochemical Characterization and Pre-clinical Anti-inflammatory Assessment.
Alshehri S; Imam SS; Altamimi MA; Hussain A; Shakeel F; Alshehri A
AAPS PharmSciTech; 2020 May; 21(5):145. PubMed ID: 32430787
[TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo evaluation of a posaconazole-sulfobutyl ether-β-cyclodextrin inclusion complex.
Wang M; Jiang J; Cai Y; Zhao M; Wu Q; Cui Y; Zhao C
Biomed Chromatogr; 2018 Dec; 32(12):e4364. PubMed ID: 30119143
[TBL] [Abstract][Full Text] [Related]
20. Preparation, Characterization, and Bioavailability of Host-Guest Inclusion Complex of Ginsenoside Re with Gamma-Cyclodextrin.
Li H; Zhang G; Wang W; Chen C; Jiao L; Wu W
Molecules; 2021 Nov; 26(23):. PubMed ID: 34885811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
